Iodine I-131 monoclonal antibody 81C6

DB16197InvestigationalProtein Based Therapies

Neuradiab is under investigation in clinical trial NCT00615186 (Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy).

Mechanism: Pharmacologically active on Tenascin
Curator reviewed
Also known as: 81c6, a murine igg2 anti-tenascin monoclonal antibody labeled with iodine 131 (I-131) · Anti-tenascin 81C6 monoclonal antibody labeled w/ I 131 · Anti-tenascin monoclonal antibody 81c6-I-131 · Iodine i 131 moab 81c6 · Iodine i 131 monoclonal antibody 81c6
Code names: 81C6 I-131

Resolves to

Compound

UNIID4E1UP3RMVCAS1000874-23-6

Targets

P24821TNC

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Iodine I-131 monoclonal antibody 81C6, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account